Cerebral Cavernous Malformation: From Genetics to Pharmacotherapy
ABSTRACT Introduction Cerebral cavernous malformation (CCM) is a type of cerebrovascular abnormality in the central nervous system linked to both germline and somatic genetic mutations. Recent preclinical and clinical studies have shown that various drugs can effectively reduce the burden of CCM les...
Saved in:
Main Authors: | Zhuangzhuang Zhang, Jianwen Deng, Weiping Sun, Zhaoxia Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2025-01-01
|
Series: | Brain and Behavior |
Subjects: | |
Online Access: | https://doi.org/10.1002/brb3.70223 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Use of balloon angioplasty for patients with intracranial large atherosclerotic acute ischemic stroke and cerebral cavernous malformation: a case report
by: Yiwan Wang, et al.
Published: (2025-01-01) -
Exploration of treatment strategies for cerebral cavernous malformations: two case reports on non-resection treatment and literature review
by: Yibo Han, et al.
Published: (2025-01-01) -
MPN/MDS OVERLAP SYNDROME ANTICIPATED BY A SEVERE BLEEDING DIATHESIS: HYPOTHESIS OF A PRE-EXISTING PLATELET DISORDER
by: Paola Ranalli, et al.
Published: (2024-08-01) -
Clinical, genomic, and histopathologic diversity in cerebral cavernous malformations
by: Jian Ren, et al.
Published: (2025-02-01) -
DeepDrug as an expert guided and AI driven drug repurposing methodology for selecting the lead combination of drugs for Alzheimer’s disease
by: Victor O. K. Li, et al.
Published: (2025-01-01)